# Capitol Federal Financial, Inc.: financial statements, quarterly

CFFN · Nasdaq · CIK 1490906 · [Financials](/sectors/financials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/cffn.md) · [Financials](/companies/cffn/financials.md) · [Filings](/companies/cffn/filings.md) · [Insiders](/companies/cffn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cffn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [57.5 d](/filings/0001490906-23-000028.md) | [52.1](/filings/0001490906-24-000014.md) | [52.0](/filings/0001490906-24-000024.md) | [54.7](/filings/0001490906-24-000028.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(45.7) d](/filings/0001490906-25-000033.md) | [(0.5)](/filings/0001490906-25-000009.md) | [3.5](/filings/0001490906-25-000014.md) | [6.0](/filings/0001490906-25-000021.md) | [7.2 d](/filings/0001490906-25-000033.md) | [3.7](/filings/0001490906-26-000011.md) | [3.9](/filings/0001490906-26-000018.md) | [3.3](/filings/0001490906-26-000025.md) | [4.2 d](/filings/0001490906-25-000033.md) | [4.9](/filings/0001490906-26-000011.md) | [4.9](/filings/0001490906-26-000018.md) | [5.7](/filings/0001490906-26-000025.md) |
| Net income | $m | [(140) d](/filings/0001490906-25-000033.md) | [2.5](/filings/0001490906-25-000021.md) | [13.8](/filings/0001490906-25-000021.md) | [9.6](/filings/0001490906-25-000021.md) | [12.1 d](/filings/0001490906-25-000033.md) | [15.4](/filings/0001490906-26-000025.md) | [15.4](/filings/0001490906-26-000025.md) | [18.4](/filings/0001490906-26-000025.md) | [18.8 d](/filings/0001490906-25-000033.md) | [20.3](/filings/0001490906-26-000025.md) | [20.1](/filings/0001490906-26-000025.md) | [23.6](/filings/0001490906-26-000025.md) |
| Diluted EPS | $ per share | not reported | [0.02](/filings/0001490906-25-000009.md) | [0.11](/filings/0001490906-25-000014.md) | [0.07](/filings/0001490906-25-000021.md) | not reported | [0.12](/filings/0001490906-26-000011.md) | [0.12](/filings/0001490906-26-000018.md) | [0.14](/filings/0001490906-26-000025.md) | not reported | [0.16](/filings/0001490906-26-000011.md) | [0.16](/filings/0001490906-26-000018.md) | [0.19](/filings/0001490906-26-000025.md) |
| Basic EPS | $ per share | not reported | [0.02](/filings/0001490906-25-000009.md) | [0.11](/filings/0001490906-25-000014.md) | [0.07](/filings/0001490906-25-000021.md) | not reported | [0.12](/filings/0001490906-26-000011.md) | [0.12](/filings/0001490906-26-000018.md) | [0.14](/filings/0001490906-26-000025.md) | not reported | [0.16](/filings/0001490906-26-000011.md) | [0.16](/filings/0001490906-26-000018.md) | [0.19](/filings/0001490906-26-000025.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001490906-24-000035.md) | [0.3](/filings/0001490906-24-000014.md) | [0.4](/filings/0001490906-24-000024.md) | [0.3](/filings/0001490906-24-000028.md) | [0.2](/filings/0001490906-25-000033.md) | [0.2](/filings/0001490906-25-000009.md) | [0.3](/filings/0001490906-25-000014.md) | [0.2](/filings/0001490906-25-000021.md) | [0.3](/filings/0001490906-26-000025.md) | [0.2](/filings/0001490906-26-000011.md) | [0.3](/filings/0001490906-26-000018.md) | [0.1](/filings/0001490906-26-000025.md) |
| Total assets | $bn | [10.2](/filings/0001490906-24-000035.md) | [9.6](/filings/0001490906-24-000014.md) | [9.7](/filings/0001490906-24-000024.md) | [9.6](/filings/0001490906-24-000028.md) | [9.5](/filings/0001490906-25-000033.md) | [9.5](/filings/0001490906-25-000009.md) | [9.7](/filings/0001490906-25-000014.md) | [9.7](/filings/0001490906-25-000021.md) | [9.8](/filings/0001490906-26-000025.md) | [9.8](/filings/0001490906-26-000011.md) | [9.8](/filings/0001490906-26-000018.md) | [9.7](/filings/0001490906-26-000025.md) |
| Total liabilities | $bn | [9.1](/filings/0001490906-24-000035.md) | [8.5](/filings/0001490906-24-000014.md) | [8.7](/filings/0001490906-24-000024.md) | [8.6](/filings/0001490906-24-000028.md) | [8.5](/filings/0001490906-25-000033.md) | [8.5](/filings/0001490906-25-000009.md) | [8.7](/filings/0001490906-25-000014.md) | [8.6](/filings/0001490906-25-000021.md) | [8.7](/filings/0001490906-26-000025.md) | [8.7](/filings/0001490906-26-000011.md) | [8.8](/filings/0001490906-26-000018.md) | [8.6](/filings/0001490906-26-000025.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.0](/filings/0001490906-25-000033.md) | [1.0](/filings/0001490906-25-000021.md) | [1.0](/filings/0001490906-25-000021.md) | [1.0](/filings/0001490906-25-000021.md) | [1.0](/filings/0001490906-26-000025.md) | [1.0](/filings/0001490906-26-000025.md) | [1.0](/filings/0001490906-26-000025.md) | [1.0](/filings/0001490906-26-000025.md) | [1.0](/filings/0001490906-26-000025.md) | [1.0](/filings/0001490906-26-000025.md) | [1.0](/filings/0001490906-26-000025.md) | [1.0](/filings/0001490906-26-000025.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [13.5 d](/filings/0001490906-25-000033.md) | [(5.3)](/filings/0001490906-25-000009.md) | [20.5 d](/filings/0001490906-25-000014.md) | [19.1 d](/filings/0001490906-25-000021.md) | [(3.1) d](/filings/0001490906-25-000033.md) | [5.6](/filings/0001490906-26-000011.md) | [15.5 d](/filings/0001490906-26-000018.md) | [12.4 d](/filings/0001490906-26-000025.md) | [21.5 d](/filings/0001490906-25-000033.md) | [17.4](/filings/0001490906-26-000011.md) | [21.4 d](/filings/0001490906-26-000018.md) | [17.4 d](/filings/0001490906-26-000025.md) |
| Capital expenditure | $m | [1.9 d](/filings/0001490906-25-000033.md) | [1.3](/filings/0001490906-25-000009.md) | [1.5 d](/filings/0001490906-25-000014.md) | [2.7 d](/filings/0001490906-25-000021.md) | [1.8 d](/filings/0001490906-25-000033.md) | [1.2](/filings/0001490906-26-000011.md) | [0.8 d](/filings/0001490906-26-000018.md) | [1.6 d](/filings/0001490906-26-000025.md) | [1.7 d](/filings/0001490906-25-000033.md) | [1.6](/filings/0001490906-26-000011.md) | [1.3 d](/filings/0001490906-26-000018.md) | [1.8 d](/filings/0001490906-26-000025.md) |
| Dividends paid | $m | [11.3 d](/filings/0001490906-25-000033.md) | [11.3](/filings/0001490906-25-000009.md) | [11.1 d](/filings/0001490906-25-000014.md) | [11.0 d](/filings/0001490906-25-000021.md) | [11.0 d](/filings/0001490906-25-000033.md) | [11.1](/filings/0001490906-26-000011.md) | [11.1 d](/filings/0001490906-26-000018.md) | [11.1 d](/filings/0001490906-26-000025.md) | [11.1 d](/filings/0001490906-25-000033.md) | [11.0](/filings/0001490906-26-000011.md) | [15.9 d](/filings/0001490906-26-000018.md) | [10.6 d](/filings/0001490906-26-000025.md) |
| Share repurchases | $m | [1.3 d](/filings/0001490906-25-000033.md) | [11.9](/filings/0001490906-25-000009.md) | [7.5 d](/filings/0001490906-25-000014.md) | [0.0 d](/filings/0001490906-25-000021.md) | [(0.0) d](/filings/0001490906-25-000033.md) | [0.0](/filings/0001490906-26-000011.md) | [0.0 d](/filings/0001490906-26-000018.md) | [0.0 d](/filings/0001490906-26-000025.md) | [3.9 d](/filings/0001490906-25-000033.md) | [16.0](/filings/0001490906-26-000011.md) | [15.8 d](/filings/0001490906-26-000018.md) | [14.2 d](/filings/0001490906-26-000025.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [135](/filings/0001490906-24-000014.md) | [133](/filings/0001490906-24-000024.md) | [133](/filings/0001490906-24-000028.md) | [132](/filings/0001490906-25-000009.md) | [131](/filings/0001490906-25-000014.md) | [130](/filings/0001490906-25-000021.md) | [130](/filings/0001490906-26-000011.md) | [130](/filings/0001490906-26-000018.md) | [130](/filings/0001490906-26-000025.md) | [129](/filings/0001490906-26-000011.md) | [127](/filings/0001490906-26-000018.md) | [124](/filings/0001490906-26-000025.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 125,698,283 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001490906-26-000025.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.